On World Tuberculosis Day 2025, PMC recognizes local companies and institutions for their significant role in TB eradication initiatives | X – @PanvelCorp
The Panvel Municipal Corporation (PMC) marked World Tuberculosis (TB) Day by honoring local companies and institutions that contributed to the corporation’s TB eradication initiatives. The event, held at the municipal headquarters on March 26, highlighted the role of social responsibility in public health efforts.
Under the National TB Elimination Program, the municipal corporation launched a 100-day TB campaign on December 7, 2025, targeting high-risk areas such as slums, brick kilns, migrant labor camps, homeless shelters, prisons, old age homes, ashram schools, hostels, construction sites, and industrial workplaces. The initiative focused on early detection, using digital portable X-ray machines to screen vulnerable populations.
As part of the campaign, 15% of the total municipal population was screened, resulting in 33,450 chest X-rays. Among them, 4,390 suspected cases underwent advanced CBNAAT testing, leading to the identification of 609 new TB patients. “All diagnosed individuals received free treatment, along with nutritional support under the Nikshay Poshan Yojana,” said an official.
Recognizing corporate contributions under Corporate Social Responsibility (CSR), the corporation honored several companies that played a key role in the campaign’s success. Indian Government Mint, Mumbai, provided four digital handheld X-ray machines, while IG Petrochemical, Deepak Fertilizer, Milan Pharma Industries, Berger Paints, Hindalco, L&T, and NMA Projects extended their support.
Additionally, MGM Medical College and Terna Medical College were felicitated for their continued collaboration with the municipal health department. Local diagnostic centers such as Pooja Diagnostic, Kalamboli, and One Export Solution were also acknowledged for their assistance in TB detection efforts.
Commissioner Chitale reiterated that TB is a notifiable disease, making it mandatory for all government and private healthcare facilities, laboratories, pharmaceutical companies, and medical institutions to report TB cases to authorities. Strict compliance with this directive is essential for effective TB control.
